Damien Denimal

1.2k total citations
43 papers, 837 citations indexed

About

Damien Denimal is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Epidemiology. According to data from OpenAlex, Damien Denimal has authored 43 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Molecular Biology and 11 papers in Epidemiology. Recurrent topics in Damien Denimal's work include Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers), Liver Disease Diagnosis and Treatment (9 papers) and Sphingolipid Metabolism and Signaling (5 papers). Damien Denimal is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers), Liver Disease Diagnosis and Treatment (9 papers) and Sphingolipid Metabolism and Signaling (5 papers). Damien Denimal collaborates with scholars based in France, United States and Belgium. Damien Denimal's co-authors include Laurence Duvillard, Benjamin Bouillet, Jean‐Michel Petit, Bruno Vergès, Romaric Loffroy, Bruno Vergès, Jean–Pierre Cercueil, Alexia Rouland, Olivier Chevallier and Thomas Mouillot and has published in prestigious journals such as The Journal of Immunology, The Journal of Clinical Endocrinology & Metabolism and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Damien Denimal

36 papers receiving 825 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Damien Denimal France 14 462 398 188 168 135 43 837
Yuan Xu China 19 352 0.8× 361 0.9× 305 1.6× 133 0.8× 107 0.8× 51 1.1k
Yaşar Çolak Türkiye 19 672 1.5× 296 0.7× 146 0.8× 163 1.0× 187 1.4× 55 1.0k
Agustín Domínguez‐Díez Spain 8 582 1.3× 287 0.7× 146 0.8× 153 0.9× 125 0.9× 12 786
T.C.M.A. Schreuder Netherlands 15 702 1.5× 313 0.8× 239 1.3× 302 1.8× 258 1.9× 21 1.1k
Enver Dolar Türkiye 15 476 1.0× 199 0.5× 177 0.9× 279 1.7× 189 1.4× 53 943
Saeed Esmaili Australia 13 792 1.7× 234 0.6× 139 0.7× 101 0.6× 351 2.6× 19 963
Jian-Gao Fan China 4 915 2.0× 383 1.0× 169 0.9× 157 0.9× 324 2.4× 5 1.2k
Paolo Conca Italy 16 906 2.0× 352 0.9× 127 0.7× 202 1.2× 407 3.0× 37 1.2k
George Marek United States 11 565 1.2× 375 0.9× 314 1.7× 111 0.7× 60 0.4× 16 1.2k
Alessandra Marrazzo Italy 5 667 1.4× 301 0.8× 80 0.4× 92 0.5× 263 1.9× 8 796

Countries citing papers authored by Damien Denimal

Since Specialization
Citations

This map shows the geographic impact of Damien Denimal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damien Denimal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damien Denimal more than expected).

Fields of papers citing papers by Damien Denimal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Damien Denimal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damien Denimal. The network helps show where Damien Denimal may publish in the future.

Co-authorship network of co-authors of Damien Denimal

This figure shows the co-authorship network connecting the top 25 collaborators of Damien Denimal. A scholar is included among the top collaborators of Damien Denimal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Damien Denimal. Damien Denimal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pilot, Thomas, Damien Denimal, Maxime Samson, et al.. (2025). Inhibition of LXR Signaling in Human Foam Cells Impairs Macrophage-to-Endothelial Cell Cross Talk and Promotes Endothelial Cell Inflammation. Arteriosclerosis Thrombosis and Vascular Biology. 45(6). 910–927. 3 indexed citations
3.
Denimal, Damien. (2025). Emerging perspectives on once-weekly insulins in type 1 and type 2 diabetes: a mini-review. Frontiers in Endocrinology. 16. 1656884–1656884.
4.
5.
Rouland, Alexia, Thomas Gautier, Damien Denimal, et al.. (2024). The Endogenous Inhibitor of CETP, apoC1, Remains Ineffective In Vivo after Correction of Hyperglycemia in People with Type 1 Diabetes. Metabolites. 14(9). 487–487.
6.
Davaine, Jean-Michel, et al.. (2024). Medial arterial calcification of the lower limbs in diabetes: Time for awareness? A short narrative review. Diabetes & Metabolism. 51(1). 101586–101586. 2 indexed citations
7.
Denimal, Damien, Maharajah Ponnaiah, Franck Phan, et al.. (2024). Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts. Cardiovascular Diabetology. 23(1). 69–69. 1 indexed citations
8.
Denimal, Damien, et al.. (2023). Vitamin B12 Status in Recreational Users of Nitrous Oxide: A Systematic Review Focusing on the Prevalence of Laboratory Abnormalities. Antioxidants. 12(6). 1191–1191. 13 indexed citations
9.
Denimal, Damien. (2023). Antioxidant and Anti-Inflammatory Functions of High-Density Lipoprotein in Type 1 and Type 2 Diabetes. Antioxidants. 13(1). 57–57. 31 indexed citations
10.
Denimal, Damien, Serge Monier, Benjamin Bouillet, Bruno Vergès, & Laurence Duvillard. (2023). High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity. Metabolites. 13(2). 253–253. 24 indexed citations
11.
Denimal, Damien, et al.. (2023). Clinical and Imaging Outcomes after Vitamin D Supplementation in Patients with Multiple Sclerosis: A Systematic Review. Nutrients. 15(8). 1945–1945. 9 indexed citations
12.
Denimal, Damien. (2023). Rethinking ‘good cholesterol’ for cardiovascular risk stratification. QJM. 117(4). 243–245. 3 indexed citations
13.
Denimal, Damien, et al.. (2023). A case of functional vitamin B12 deficiency after recreational nitrous oxide use. Biochemia Medica. 34(1). 117–123. 2 indexed citations
14.
Denimal, Damien. (2023). Carbamylated lipoproteins in diabetes. World Journal of Diabetes. 14(3). 159–169. 3 indexed citations
15.
Denimal, Damien, Serge Monier, Isabelle Simoneau, et al.. (2022). Normal HDL Cholesterol Efflux and Anti-Inflammatory Capacities in Type 2 Diabetes Despite Lipidomic Abnormalities. The Journal of Clinical Endocrinology & Metabolism. 107(9). e3816–e3823. 17 indexed citations
16.
Denimal, Damien, Serge Monier, Isabelle Simoneau, et al.. (2022). HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control. Cardiovascular Diabetology. 21(1). 154–154. 7 indexed citations
17.
Nguyen, Maxime, Damien Denimal, Auguste Dargent, et al.. (2018). Plasma Renin Concentration is Associated With Hemodynamic Deficiency and Adverse Renal Outcome in Septic Shock. Shock. 52(4). e22–e30. 21 indexed citations
18.
Denimal, Damien, Stéphanie Roux, & Laurence Duvillard. (2017). Evaluation of the new restandardized 25-hydroxyvitamin D assay on the iSYS platform. Clinical Biochemistry. 52. 156–160. 5 indexed citations
19.
Denimal, Damien, Marie‐Claude Brindisi, Stéphanie Barrère‐Lemaire, & Laurence Duvillard. (2016). Assessment of Folate Status in Obese Patients: Should We Measure Folate in Serum or in Red Blood Cells?. Obesity Surgery. 26(12). 3069–3075. 1 indexed citations
20.
Denimal, Damien, Jean-Paul Paı̈s de Barros, Jean‐Michel Petit, et al.. (2015). Significant abnormalities of the HDL phosphosphingolipidome in type 1 diabetes despite normal HDL cholesterol concentration. Atherosclerosis. 241(2). 752–760. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuan Xu Breakdown of academic impact, for papers by Yaşar Çolak Breakdown of academic impact, for papers by Agustín Domínguez‐Díez Breakdown of academic impact, for papers by T.C.M.A. Schreuder Breakdown of academic impact, for papers by Enver Dolar Breakdown of academic impact, for papers by Saeed Esmaili Breakdown of academic impact, for papers by Jian-Gao Fan Breakdown of academic impact, for papers by Paolo Conca Breakdown of academic impact, for papers by George Marek Breakdown of academic impact, for papers by Alessandra Marrazzo
Rankless by CCL
2026